Pfizer announced Monday that trials showed its COVID-19 vaccine to be safe and elicited a “robust” antibody response in children ages 5 to 11. These are the first known results of its kind for a COVID-19 vaccine in this age group in the US The data, however, has not yet been peer-reviewed or officially published. However, Pfizer plans to soon submit the documents to the US Food and Drug Administration to request an emergency use authorization for minors.
Heartbreaking lifeguard testimony. That's how he found out about his daughter's death 4:46 (Trends Wide) -- Tuesday's fatal shooting of 19 children and two adults in Uvalde, Texas,...
Read more
A trader works on the floor of the New York Stock Exchange at the closing bell, January 14, 2022. TIMOTHY A. CLARY/AFP The Fed gave, the Fed took...
Read more
In 4 previous articles, I dealt with the issue of mercy for the non-Muslim from multiple approaches: verbal, jurisprudential and ethical; In order to diversify the arguments and...
Read more
The teenager who killed 19 children and two adults warned in a private message on a social network shortly before the event that he was going to shoot...
Read more
France’s Le Monde newspaper described the United States as a country “trapped in madness” after yet another mass shooting at a school claimed the lives of 19 children...
Read more
